The Heavy Chain Diseases: Clinical and Pathologic Features
Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience - Clinical Lymphoma, Myeloma and Leukemia
Detection of Plasma Cell Disorders by Mass Spectrometry: A Comprehensive Review of 19,523 Cases - Mayo Clinic Proceedings
The Heavy Chain Diseases: Clinical and Pathologic Features
PDF) Biochemical and aggregation analysis of Bence Jones proteins from different light chain diseases
Immunoglobulin-Related Amyloidosis: Practice Essentials, Pathophysiology, Etiology
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management - ScienceDirect
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management - Maciocia - 2017 - Hematological Oncology - Wiley Online Library
Multiple Myeloma: Diagnosis and Treatment - Mayo Clinic Proceedings
Diagnosis and Treatment of Cardiac Amyloidosis Related to Plasma Cell Dyscrasias - Cardiology Clinics
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal
Multiple myeloma - The Lancet
CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis - Mayo Clinic Proceedings
Cancers | Free Full-Text | Immunoglobulin M Paraproteinaemias | HTML
Renal Monoclonal Immunoglobulin Deposition Disease: A Report of 64 Patients from a Single Institution | American Society of Nephrology
JCM | Free Full-Text | Physiology, Diagnosis and Treatment of Cardiac Light Chain Amyloidosis | HTML
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Update on treatment of light chain amyloidosis | Haematologica
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update - Mayo Clinic Proceedings
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis | NEJM
Evidence for Transition From Light Chain Deposition Disease by Immunofluorescence-Only to Classic Light Chain Deposition Disease - Kidney International Reports
The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - Kidney International
Cutaneous manifestations of monoclonal gammopathy | Blood Cancer Journal
The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis - Kidney International
